# Junta clínica — PT-pseudo_1185f6a68df0 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_1185f6a68df0",
  "pid": "PT-pseudo_1185f6a68df0",
  "task": 1,
  "psa": 7.0,
  "age": 63,
  "months": 2,
  "pirads": "5",
  "psad": 0.329,
  "psav": 1.09,
  "psap": 5.5,
  "vol": 21.27,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.8321669,
  "medhx": "Atrial fibrillation",
  "meds": "apixaban, metoprolol",
  "notes": "PSA 7 ng/mL. PI-RADS 5. PSAD 0.33. Prostate volume 21 mL. csPCa 0.83.",
  "pmhx": [
    "Atrial fibrillation"
  ],
  "allergies": [],
  "vitals": {
    "weight": "101 kg",
    "height": "179 cm",
    "bmi": "31.5",
    "bp": "100/66 mmHg",
    "hr": "72 bpm",
    "smoking": "Ex-smoker (22 pack-yr, quit 2021)",
    "last_dental": "6 mo ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Feb 2025",
  "enc_ref": "Dr. P. van Dijk (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Escalating prostate-specific antigen measurements across a two-year span prompted a recent multiparametric magnetic resonance imaging study."
    },
    {
      "s": "History",
      "t": "At sixty-three years of age, this retired mechanical engineer first entered clinical evaluation in early 2023 due to a PSA elevation, which has since steadily ascended to 7.0 ng/mL. His urological documentation indicates a prior biopsy bucket of None. Lower urinary tract complaints remain minimal, characterized by slight hesitancy and a modest increase in nocturia, yielding an IPSS score of 7. He explicitly denies hematuria or pelvic discomfort. Physical activity persists through cycling roughly 30 kilometres three times weekly, although advancing joint stiffness necessitates a walking frame for extended distances. He shares his home with his wife, while their grown daughter handles administrative correspondence. His clinical background includes atrial fibrillation, managed with apixaban and metoprolol. A substantial smoking history of 22 pack-years was successfully abandoned in 2021. Aside from receiving a standard influenza vaccination last week and maintaining stable blood pressure readings, he reports feeling generally well, with no complaints of unexplained fatigue or weight reduction."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and uniformly firm; mobility: unrestricted; asymmetry: absent. General inspection reveals a well-nourished individual in no acute distress. Vital signs demonstrate a regular heart rate of 72 beats per minute alongside a blood pressure of 100/66 mmHg. Peripheral pulses remain palpable, and there is no clinical evidence of peripheral oedema or lymphadenopathy."
    }
  ],
  "occupation": "retired mechanical engineer",
  "marital": "Married",
  "living": "Lives with partner",
  "next_of_kin": "Adult daughter (primary contact)",
  "recent_other": [
    "GP practice nurse — flu vaccination"
  ],
  "alcohol": "5 units / week",
  "exercise": "Cycling 3x/week, ~30 km",
  "ipss": "IPSS score: 7/35 (mild LUTS)",
  "admin": "Mobility limitation (frame); ground-floor consult room preferred.",
  "mri_hospital": "Maastricht UMC+",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_1185f6a68df0
Task: 1

Encounter: Urology - outpatient on 22 Feb 2025.
Referrer: Dr. P. van Dijk (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 7.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.329 ng/mL²
  - PSA velocity: 1.09 ng/mL/yr
  - Prior PSA: 5.5 ng/mL
  - Prostate volume: 21.27 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8321669 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Atrial fibrillation
  - Problem list / PMHx: Atrial fibrillation
  - Current medication: apixaban, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 7 ng/mL. PI-RADS 5. PSAD 0.33. Prostate volume 21 mL. csPCa 0.83.

Vitals: weight 101 kg, height 179 cm, BMI 31.5, BP 100/66 mmHg, HR 72 bpm. Smoking: Ex-smoker (22 pack-yr, quit 2021).

Chief complaint: Escalating prostate-specific antigen measurements across a two-year span prompted a recent multiparametric magnetic resonance imaging study.

History: At sixty-three years of age, this retired mechanical engineer first entered clinical evaluation in early 2023 due to a PSA elevation, which has since steadily ascended to 7.0 ng/mL. His urological documentation indicates a prior biopsy bucket of None. Lower urinary tract complaints remain minimal, characterized by slight hesitancy and a modest increase in nocturia, yielding an IPSS score of 7. He explicitly denies hematuria or pelvic discomfort. Physical activity persists through cycling roughly 30 kilometres three times weekly, although advancing joint stiffness necessitates a walking frame for extended distances. He shares his home with his wife, while their grown daughter handles administrative correspondence. His clinical background includes atrial fibrillation, managed with apixaban and metoprolol. A substantial smoking history of 22 pack-years was successfully abandoned in 2021. Aside from receiving a standard influenza vaccination last week and maintaining stable blood pressure readings, he reports feeling generally well, with no complaints of unexplained fatigue or weight reduction.

Physical examination: DRE — texture: smooth and uniformly firm; mobility: unrestricted; asymmetry: absent. General inspection reveals a well-nourished individual in no acute distress. Vital signs demonstrate a regular heart rate of 72 beats per minute alongside a blood pressure of 100/66 mmHg. Peripheral pulses remain palpable, and there is no clinical evidence of peripheral oedema or lymphadenopathy.

Patient info: retired mechanical engineer; Married; Lives with partner.
Next of kin: Adult daughter (primary contact).

Lifestyle: alcohol 5 units / week; exercise Cycling 3x/week, ~30 km; IPSS score: 7/35 (mild LUTS).

Recent other appointments: GP practice nurse — flu vaccination.
Admin: Mobility limitation (frame); ground-floor consult room preferred.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.88
  uncertainty  +/- 0.06 epistemic (95% band 0.77-0.99); among patients I cannot tell apart the outcome was 0.54 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 63 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 7 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 21.27 mL (1% of my signal; from log_vol, vol) · PSA density = 0.329 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.83 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 5
  important  prior biopsy = None
  noted      age = 63 · DRE = Normal · PSA = 7 ng/mL · prostate volume = 21.27 mL · PSA density = 0.329 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 24 of 24 labelled cases

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 23 men I have seen in this same situation (None prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 0.49: PI-RADS 5, PSA 9.0, PSAD 0.409, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P5 in a man with high PSA"
  2. distance 0.79: PI-RADS 5, PSA 5.9, PSAD 0.199, age 60, DRE Normal -> BIOPSY (clear). He wrote: "PIRADS 5 in a 60 year old man"
  3. distance 1.21: PI-RADS 5, PSA 5.5, PSAD 0.136, age 61, DRE Normal -> BIOPSY (clear). He wrote: "Biopsy naive PIRADS 5 needs biopsy"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 5
  important  age = 63 · PSA = 7 ng/mL
  noted      prior biopsy = None · DRE = Normal · prostate volume = 21.27 mL · PSA density = 0.329 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: clear — the precedents agree (1.00) and the library is right 92% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 23 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 5
  important  age = 63 · PSA = 7 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · DRE = Normal · prostate volume = 21.27 mL · PSA density = 0.329 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS score of 3 or higher mandates a biopsy. The retrieved passage states: "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.88 is high, but the guideline treats the PI-RADS score as the primary trigger. The guideline suggests that a PI-RADS score of 3 or higher is the threshold for biopsy, regardless of other variables. The guideline makes the PI-RADS score decisive, whereas EXPERT-STRUCTURED marked prior biopsy = None as decisive. The guideline requires the PI-RADS score, which is already known, and does not account for the prior biopsy status as a decisive factor. The guideline needs the prior grade of the prior biopsy to determine the next step, which is not represented by any panel variable.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: at None the guideline suggests biopsy is indicated if PI-RADS $\ge 3$, meaning the indication stands regardless of the prior status.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the guideline does not explicitly state how the PSA trend modifies the PI-RADS threshold for biopsy.
laboratory_results - the laboratory results: the guideline does not explicitly state how the PSA density modifies the PI-RADS threshold for biopsy.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case strongly points towards biopsy based on the PI-RADS score and the guideline, but we need to establish the context from the radiology report and previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Must clarify if the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Must clarify how the PSA trend modifies the PI-RADS threshold for biopsy.
  previous_notes (get_previous_notes) -> Must clarify the GRADE of the prior biopsy, if any, and whether a surveillance protocol is in place.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What must the radiology_report answer regarding whether the lesion is compared against an earlier study?
  Q2. What must the previous_notes answer regarding the GRADE of the prior biopsy, if any, and whether a surveillance protocol is in place?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report: "Maastricht UMC+ | Radiology | 18 February 2025 | Multiparametric MRI Prostate. COMPARISON: new. LESION: PI-RADS 5 lesion located in the left peripheral zone (mid-gland), spanning approximately 12 x 9 mm."
psa_trend: "PSA 1.3 (Mar 2023) rising to 3.0 (Feb 2024), rising to 7.0 (Feb 2025)."
previous_notes: "Date: 05 Mar 2023, Author: Dr. P. van Dijk (GP), Text: A routine cardiovascular risk assessment uncovered a prostate-specific antigen level of 4.8 ng/mL, surpassing the age-adjusted local benchmark. Following a discussion on the clinical significance of this elevation, the individual was instructed to schedule a repeat measurement in half a year."

WHAT I DID NOT OPEN
laboratory_results and family-history of prostate cancer.

WHAT THIS SUPPORTS
FOR sampling this patient now:
- radiology_report: PI-RADS 5 lesion located in the left peripheral zone (mid-gland), spanning approximately 12 x 9 mm.
- psa_trend: PSA 1.3 (Mar 2023) rising to 3.0 (Feb 2024), rising to 7.0 (Feb 2025).
AGAINST sampling this patient now:
- previous_notes: The prior biopsy status is noted as "None," but the note does not specify a GRADE or surveillance protocol.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.00 ng/mL over 3 points spanning 23 months; velocity +2.99 ng/mL per year; doubling time about 9 months.
PROJECTION at 6 months: 10.0 ng/mL, conformal 95% band 2.9-34.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 7 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.86
  uncertainty  +/- 0.05 epistemic (95% band 0.76-0.96), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 7 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 21.27 mL (4% of my signal; from log_vol, vol) · PSA density = 0.329 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.88  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.86  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-EXPERIENCE  BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           None                         E1:DEC E3:DEC cohort:IMP library:not E2:—            -> noted
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:— E2:—                    -> not_used (raised from noted by the board)
  age          63                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          7 ng/mL                      E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          21.27 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.329                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.83                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> decisive
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have addressed the moderator's questions. The radiology report clarified that the lesion is compared against a new study, and the previous notes indicated a prior biopsy status of "None" without specifying a GRADE or surveillance protocol.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of BIOPSY, as the cohort criterion (PI-RADS $\ge 3$) fired, which is the rule that determined the panel's decision.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What must the radiology_report answer regarding whether the lesion is compared against an earlier study? The radiology report answered this, stating the comparison is "new."
Q2. What must the previous_notes answer regarding the GRADE of the prior biopsy, if any, and whether a surveillance protocol is in place? The previous notes indicated "None" for prior biopsy but did not specify a GRADE or surveillance protocol.

WHAT CARRIES WEIGHT, AND WHY
<pirads>: decisive: 5 (The PI-RADS score of 5 was decisive as per EXPERT-COHORT and EXPERT-EXPERIENCE, matching the guideline trigger.)
<prior biopsy>: decisive: None (This was decisive for EXPERT-STRUCTURED and EXPERT-FUSION, driving the panel decision.)
<psa>: important: 7 ng/mL (This was important for EXPERT-STRUCTURED and EXPERT-TRACE, contributing to the overall high probability.)
My confidence in the record as it stands is clear, as the necessary documents were retrieved to address the moderator's questions.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the PI-RADS 5 score meets the guideline threshold, and the retrieved information confirms the lack of prior biopsy status.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

63 y/o male, biopsy-naive, with PI-RADS 5 and PSA density 0.329. The PI-RADS 5 finding mandates biopsy, supported by the absence of prior pathology. PSA trend is rising, and no prior biopsy grade is recorded, making the imaging finding the deciding factor.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
